GRIFOLS S.A. (GRF.MC) Financials

GRF.MC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 22.1 billion 13.5 billion
2023-06-30 21.4 billion 13.2 billion
2023-03-31 21.4 billion 15.5 billion
2022-12-31 21.5 billion 13.1 billion

GRF.MC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 ? ?
2023-06-30 ? ?
2023-03-31 ? ?
2022-12-31 ? ?

GRF.MC Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-09-30 59.5 million
2023-06-30 52.0 million
2023-03-31 -108.3 million
2022-12-31 32.3 million

GRF.MC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 543.6 million - -
2023-06-30 557.2 million 9.4 billion -
2023-03-31 464.0 million 10.0 billion -
2022-12-31 578.6 million - 1.0 billion

GRF.MC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 678.4 million
2023-06-30 678.4 million
2023-03-31 678.4 million
2022-12-31 678.4 million

GRF.MC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 88.4 million 300.3 million -
2023-06-30 126.1 million 87.3 million 292.1 million -
2023-03-31 63.5 million - 413.7 million -
2022-12-31 76.8 million 106.2 million 329.7 million -

GRF.MC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.6 billion 965.6 million
2023-06-30 1.7 billion 1.0 billion
2023-03-31 1.6 billion 1.0 billion
2022-12-31 1.7 billion 1.1 billion

GRF.MC

Price: €8.65

52 week price:
6.36
15.92

Earnings Per Share: 0.09 EUR

P/E Ratio: 267.25

Exchange: MCE

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 1.1 million

Market Capitalization: 5.3 billion

Average Dividend Frequency: 2

Links: